ARCHIVES

In Brief: ACR Moving To D.C.; FDA Advisors OK VP-16 NDA; Wiernik Tells Missouri No; Dewys Moves To DRCCA

This article is from The Cancer Letter archive.

Vol. 08 No. 40 | October 15, 1982

Download PDF Visit The Full Archive

Related Articles

Study Finds Nearly Two-Thirds Of Children Return to Hospital Following Stem Cell Transplant

April 26, 2013

NCAB Oks LANs To Links NCI Staff With Each Other, The World

February 14, 1992

In Brief: Golomb, Weinstein Head ASCO, AACR; Abeloff, Moses Presidents Elect; Sackett Heads AUR

June 1, 1990

FDA Official Outlines agency’s Views On Efficacy Requirement

June 16, 1999

Talactoferrin Second-Line Therapy Increases Survival In Stage IIIB/IV

October 28, 2011

Illinois Congressman Calls For Full Bypass Budget Appropriation In cancer Prevention – $180 Million

February 22, 1991